这是描述信息
Search
Submit
Cancel
Nanjing RegeneCore Biotech Co.,Ltd
Nanjing RegeneCore Biotech Co.,Ltd

REGENECORE is an innovative start-up company under the YOUNGY Group, advocating science and culture, paying attention to the growth of employees and enterprises, and maintaining human health.

Nanjing RegeneCore Biotech Co.,Ltd
Nanjing RegeneCore Biotech Co.,Ltd

Mature and complete nanobody humanization technology platform, antibody immunogenicity detection technology platform, and high-throughput nanobody screening technology platform.

这是描述信息

Nanjing RegeneCore Biotech Co.,Ltd

Nanjing RegeneCore Biotech Co.,Ltd is established in the Biomedical Valley of National Nanjing Jiangbei New Area, with a research and office base of nearly 4000 square meters. It is one of the first research and development institutions in the field of nanobodies in China. The company's international scientific consulting expert team has rich experience in the research and development of cell therapy products and clinical applications, providing strong guarantees for the precise positioning and success rate of research and development products. The company has mature and leading nanobody screening technology, and conducts in-depth development in multiple application fields based on this technology.

more
company

Technology Platform

 

Platforms

High throughput nanobody screening technology platform, nanobody humanization technology platform, antibody immunogenicity detection technology platform, biomacromolecule analysis technology platform, antibody drug CMC process development technology platform

R&D Pipeline

Autoimmune disease treatment pipeline

Tumor therapy

product pipeline

Anti tumor product pipeline based on NK activation

Nervous system disease treatment product pipeline

Precise delivery product pipeline based on nanobody

NEWS

Learn more about RegeneCore news

REGENECORE  Annual  Ceremony | Unity, Innovation, and Win the Future

REGENECORE Annual Ceremony | Unity, Innovation, and Win the Future

On January 18th, the theme annual meeting of "Unity, Innovation, and Win Win Future" of REGENECORE was successfully held in Nanjing, with the participation of all employees of the company.
All employees of REGENECORE carry out the Red Party Building Activity in the Ta-pieh Mountains

All employees of REGENECORE carry out the Red Party Building Activity in the Ta-pieh Mountains

All employees of REGENECORE went to the Dabie Mountains to carry out the red party building activity of "Rewalking the Long March Road and Advancing a New Journey".
REGENECORE is the world's first IL4Rα-IL5 double antibody completed the first subject administration

REGENECORE is the world's first IL4Rα-IL5 double antibody completed the first subject administration

REGENECORE antibody drugs development enter the clinical research stage

TEL:

025-58608860

Address: Room 07 Building 16 Treehouse, No. 73, Tanmi Road, Jiangbei New District, Nanjing

Enterprise email:rjk@regenecore.com

 

这是描述信息

WeChat cooperative consultation

www.300.cn   nanjing   备案号:ICP18030131-1